Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Molycorp Posts $26.6 Mln Profit In Q4

Molycorp Inc (MCP: Quote) reported fourth quarter of 2011 net income attributable to common stockholders was $26.6 million, or $0.26 per share. Adjusted EPS of $0.41 per share takes into account certain non-cash and other out-of-ordinary operational and business expansion items as compared to U.S. GAAP earnings per share.

Quarterly net revenues were $132.9 million, significantly higher than $21.7 million in the fourth quarter of 2010.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $134.95 million for the quarter. Analysts' estimates typically exclude special items.

The Company re-affirmed its annual production of REO equivalent products to be in a range of 8,000 metric tons to 10,000 metric tons for the full year 2012.

Click here to receive FREE breaking news email alerts for Molycorp, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.